AbbVie Inc. vs OptiNose, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- AbbVie Inc. is the larger company by market value: $514.0 B against $135 M for OptiNose, Inc., 3807 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for OptiNose, Inc.). OptiNose, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- AbbVie Inc. had more revenue: $61.2 B in the year to December 2025 against $49 M for OptiNose, Inc. in the year to December 2020.
- AbbVie Inc. made a net profit of $4.2 B, while OptiNose, Inc. made a net loss of $100 M.
- AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -203.1% for OptiNose, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | AbbVie Inc. ABBV · #26 in the world | OptiNose, Inc. OPTN |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 2013 | 2010 |
| Size | ||
| Market cap | $514.0 B | $135 M* |
| Revenue | $61.2 B | $49 M |
| Net income | $4.2 B▲ best | $-100 M |
| Employees | 57,000 | — |
| Valuation | ||
| P/E ratio | 49.7× | — |
| Price to sales | 7.8× | — |
| Free cash flow yield | 3.5% | — |
| Profitability | ||
| Gross margin | 70.2% | — |
| Operating margin | 24.6% | — |
| Net margin | 6.9% | — |
| Return on invested capital | 16.0% | — |
| Growth | ||
| Revenue growth | 8.6% | — |
| Revenue growth, 3 years a year | 1.8% | — |
| Earnings per share growth | -1.3% | — |
| Financial strength | ||
| Interest cover | 5.2× | — |
| Cash | ||
| Free cash flow margin | 29.1% | — |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.5% | — |
| Strength scores | ||
| Piotroski F-score | 8 of 9 | — |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, AbbVie Inc. or OptiNose, Inc.?
AbbVie Inc. is the larger company by market value: $514.0 B against $135 M for OptiNose, Inc., 3807 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for OptiNose, Inc.). OptiNose, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, AbbVie Inc. or OptiNose, Inc.?
AbbVie Inc. had more revenue: $61.2 B in the year to December 2025 against $49 M for OptiNose, Inc. in the year to December 2020. AbbVie Inc. made a net profit of $4.2 B, while OptiNose, Inc. made a net loss of $100 M.
Which is more profitable, AbbVie Inc. or OptiNose, Inc.?
AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -203.1% for OptiNose, Inc.
More about AbbVie Inc.
More about OptiNose, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.